Abstract
The Octamer 4 gene (Oct4) is a master pluripotency controller that has been detected in several types of tumors. Here, we examine the expression of Oct4 in human esophageal squamous cell carcinoma (ESCC). We found that punctate Oct4 protein was expressed in most (93.7%) ESCC samples but it was not observed in esophageal mucosa. Some ESCC cells had the capacity to form tumorospheres; those with an Oct4+-rich cell phenotype had increased proliferation and Oct4 mRNA levels compared to those of differentiated cells in culture or xenograft tumors. The over-expression of Oct4 in ESCCs suggests that it is a potential target for ESCC therapy. Oct4 could be a useful tumor marker in an immunohistochemical panel designed to differentiate between ESCC and esophageal mucosa. Expression of Oct4 in tumorospheres might indicate the presence of a population of ECSCs and its expression in xenograft tumors suggests that Oct4 is also associated with tumor metastasis.
Similar content being viewed by others
References
Adachi, K., Suemori, H., Yasuda, S.Y., Nakatsuji, N., and Kawase, E. (2010). Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 15, 455–470.
Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983–3988.
Atlasi, Y., Mowla, S.J., Ziaee, S.A., and Bahrami, A.R. (2007). OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int. J. Cancer 120, 1598–1602.
Chen, Z., Xu, W.R., Qian, H., Zhu, W., Bu, X.F., Wang, S., Yan, Y.M., Mao, F., Gu, H.B., Cao, H.L., et al. (2009). Oct4, a novel marker for human gastric cancer. J. Surg. Oncol. 99, 414–419.
Cheng, L., Thomas, A., Roth, L.M., Zheng, W., Michael, H., and Karim, F.W. (2004). OCT4: a novel biomarker for dysgerminoma of the ovary. Am. J. Surg. Pathol. 28, 1341–1346.
Cheng, L., Sung, M.T., Cossu-Rocca, P., Jones, T.D., MacLennan, G.T., De Jong, J., Lopez-Beltran, A., Montironi, R., and Looijenga, L.H. (2007). OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J. Pathol. 211, 1–9.
Chiou, S.H., Yu, C.C., Huang, C.Y., Lin, S.C., Liu, C.J., Tsai, T.H., Chou, S.H., Chien, C.S., Ku, H.H., and Lo, J.F. (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 14, 4085–4095.
Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., and Maitland, N.J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946–10951.
Ebben, J.D., Treisman, D.M., Zorniak, M., Kutty, R.G., Clark, P.A., and Kuo, J.S. (2010). The cancer stem cell paradigm: a new understanding of tumor development and treatment. Exp. Opin. Ther. Targets 14, 621–632.
Enzinger, P.C., and Mayer, R.J. (2003). Esophageal cancer. N. Engl. J. Med. 349, 2241–2252.
Ezeh, U.I., Turek, P.J., Reijo, R.A., and Clark, A.T. (2005). Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104, 2255–2265.
Gangemi, R.M., Griffero, F., Marubbi, D., Perera, M., Capra, M.C., Malatesta, P., Ravetti, G.L., Zona, G.L., Daga, A., and Corte, G. (2009). SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27, 40–48.
Gao, J.X. (2008). Cancer stem cells: the lessons from pre-cancerous stem cells. J. Cell. Mol. Med. 12, 67–96.
Haraguchi, N., Inoue, H., Tanaka, F., Mimori, K., Utsunomiya, T., Sasaki, A., and Mori, M. (2006a). Cancer stem cells in human gastrointestinal cancers. Hum. Cell 19, 24–29.
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G.F., and Mori, M. (2006b). Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 24, 506–513.
Hu, T., Liu, S., Breiter, D.R., Wang, F., Tang, Y., and Sun, S. (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res. 68, 6533–6540.
Hussenet, T., and du Manoir, S. (2010). SOX2 in squamous cell carcinoma: Amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 9, 1480–1486.
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71–96.
Jensen, J.B., and Parmar, M. (2006). Strengths and limitations of the neurosphere culture system. Mol. Neurobiol. 34, 153–161.
Jones, T., Ulbright, T., Eble, J., Baldridge, L., and Cheng, L. (2004). OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am. J. Surg. Pathol. 28, 935–940.
Li, C., Heidt, D.G., Dalerba, P., Burant, C.F., Zhang, L., Adsay, V., Wicha, M., Clarke, M.F., and Simeone, D.M. (2007). Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030–1037.
Loebinger, M.R., Giangreco, A., Groot, K.R., Prichard, L., Allen, K., Simpson, C., Bazley, L., Navani, N., Tibrewal, S., Davies, D., et al. (2008). Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br. J. Cancer 98, 380–387.
Long, K.B., and Hornick, J.L. (2009). SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract. Hum. Pathol. 40, 1768–1773.
Looijenga, L.H., Stoop, H., de Leeuw, H.P., de Gouveia Brazao, C.A., Gillis, A.J., van Roozendaal, K.E., van Zoelen, E.J., Weber, R.F., Wolffenbuttel, K.P., van Dekken, H., et al. (2003). POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63, 2244–2250.
Morrison, S.J., Shah, N.M., and Anderson, D.J. (1997). Regulatory mechanisms in stem cell biology. Cell 88, 287–298.
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Scholer, H., and Smith, A. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–391.
Okumura-Nakanishi, S., Saito, M., Niwa, H., and Ishikawa, F. (2005). Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280, 5307–5317.
Phi, J.H., Park, S.H., Paek, S.H., Kim, S.K., Lee, Y.J., Park, C.K., Cho, B.K., Lee, D.H., and Wang, K.C. (2007). Expression of Sox2 in mature and immature teratomas of central nervous system. Mod. Pathol. 20, 742–748.
Prasad, N.B., Biankin, A.V., Fukushima, N., Maitra, A., Dhara, S., Elkahloun, A.G., Hruban, R.H., Goggins, M., and Leach, S.D. (2005). Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 65, 1619–1626.
Reya, T., Morrison, S.J., Clarke, M.F. and Weissman, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105–111.
Schmitz, M., Temme, A., Senner, V., Ebner, R., Schwind, S., Stevanovic, S., Wehner, R., Schackert, G., Schackert, H.K., Fussel, M., et al. (2007). Identification of SOX2 as a novel gliomaassociated antigen and potential target for T cell-based immunotherapy. Br. J. Cancer 96, 1293–1301.
Sell, S. (2010). On the stem cell origin of cancer. Am. J. Pathol. 176, 2584–494.
Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D. and Dirks, P.B. (2004). Identification of human brain tumour initiating cells. Nature 432, 396–401.
Tysnes, B.B. (2010). Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia 12, 506–515.
Zhang, X., Komaki, R., Wang, L., Fang, B., and Chang, J.Y. (2008). Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clin. Cancer Res. 14, 2813–2823.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Zhou, X., Huang, GR. & Hu, P. Over-expression of Oct4 in human esophageal squamous cell carcinoma. Mol Cells 32, 39–45 (2011). https://doi.org/10.1007/s10059-011-2315-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-011-2315-5